Bleomycin-Induced Lung Toxicity in Hodgkin's Lymphoma: Risk Factors in the Positron Emission Tomography Era

Introduction Bleomycin is a major antimitotic agent in the first-line treatment for Hodgkin's lymphoma. The main limitation of its use is its pulmonary toxicity. The objectives of this study are to find out the risk factors for the occurrence of bleomycin-induced lung toxicity in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Jennane, Selim, Ababou, Mounir, El Haddad, Mariyam, Ait Sahel, Omar, Mahtat, El Mehdi, El Maaroufi, Hicham, Doudouh, Abderrahim, Doghmi, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994685/
https://www.ncbi.nlm.nih.gov/pubmed/35419251
http://dx.doi.org/10.7759/cureus.23993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994685/
https://www.ncbi.nlm.nih.gov/pubmed/35419251
http://dx.doi.org/10.7759/cureus.23993

Ejemplares similares